ATE150977T1 - Markiertes monocyte-chemoattractant- proteinmaterial und medizinische anwendung - Google Patents

Markiertes monocyte-chemoattractant- proteinmaterial und medizinische anwendung

Info

Publication number
ATE150977T1
ATE150977T1 AT93924293T AT93924293T ATE150977T1 AT E150977 T1 ATE150977 T1 AT E150977T1 AT 93924293 T AT93924293 T AT 93924293T AT 93924293 T AT93924293 T AT 93924293T AT E150977 T1 ATE150977 T1 AT E150977T1
Authority
AT
Austria
Prior art keywords
protein material
medical application
chemoattractant protein
monocyte chemoattractant
target site
Prior art date
Application number
AT93924293T
Other languages
English (en)
Inventor
Steven L Kunkel
Leon R Lyle
Robert M Strieter
Original Assignee
Mallinckrodt Medical Inc
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Medical Inc, Univ Michigan filed Critical Mallinckrodt Medical Inc
Application granted granted Critical
Publication of ATE150977T1 publication Critical patent/ATE150977T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT93924293T 1992-10-05 1993-10-04 Markiertes monocyte-chemoattractant- proteinmaterial und medizinische anwendung ATE150977T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/956,862 US5413778A (en) 1992-10-05 1992-10-05 Labelled monocyte chemoattractant protein material and medical uses thereof

Publications (1)

Publication Number Publication Date
ATE150977T1 true ATE150977T1 (de) 1997-04-15

Family

ID=25498783

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93924293T ATE150977T1 (de) 1992-10-05 1993-10-04 Markiertes monocyte-chemoattractant- proteinmaterial und medizinische anwendung

Country Status (8)

Country Link
US (1) US5413778A (de)
EP (1) EP0662843B1 (de)
JP (1) JPH08502075A (de)
AT (1) ATE150977T1 (de)
AU (1) AU674039B2 (de)
CA (1) CA2145983C (de)
DE (1) DE69309479T2 (de)
WO (1) WO1994007542A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663450A (en) * 1993-08-17 1997-09-02 Cv Therapeutics Macrophage lipid chemoattractant
ATE347594T1 (de) * 1994-01-13 2006-12-15 Univ California Monocyten protein rezeptoren aus säugern, mit chemoattraktion auslösender wirkung
US6664367B1 (en) * 1994-07-21 2003-12-16 Biosynthema, Inc. Stable analogs of bioactive peptides containing disulfide linkages
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US5981230A (en) * 1994-08-23 1999-11-09 Human Genome Sciences, Inc. Polynucleotide encoding chemokine β-4
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US6320023B1 (en) 1995-06-07 2001-11-20 Icos Corporation Macrophage derived chemokine
US7018627B1 (en) 1995-06-07 2006-03-28 Icos Corporation Macrophage derived chemokine (MDC), MDC analogs, MDC inhibitor substances, and uses thereof
US6790947B1 (en) 1995-06-07 2004-09-14 Icos Corporation Polynucleotides encoding macrophage derived chemokine
US6737513B1 (en) 1996-06-07 2004-05-18 Icos Corporation Macrophage derived chemokine (MDC) and chemokine analogs and assay to identify modulators of MDC activity, and therapeutic uses for same
US5932703A (en) * 1995-06-07 1999-08-03 Icos Corporation Macrophage derived chemokine and chemokine analogs
US6498015B1 (en) 1995-06-07 2002-12-24 Icos Corporation Methods of identifying agents that modulate the binding between MDC and an MDC receptor
US5688927A (en) * 1995-06-07 1997-11-18 Icos Corporation Macrophage derived chemokine
US6290948B1 (en) * 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10
WO1998014573A1 (en) * 1996-09-30 1998-04-09 The General Hospital Corporation Mcp-4 and mcp-5: novel chemokines
US6673915B1 (en) 1996-09-30 2004-01-06 General Hospital Corporation Nucleic acid encoding monocyte chemotactic protein 4
HUP0000316A2 (en) * 1996-11-15 2000-07-28 Exodus chemokine materials and methods
US6204024B1 (en) 1997-09-12 2001-03-20 Akzo Nobel N.V. CCR5 RNA transcription based amplification assay
US6541623B1 (en) 1998-04-03 2003-04-01 Hyseq, Inc. Interleukin—1 receptor antagonist and uses thereof
US6294655B1 (en) 1998-04-03 2001-09-25 Hyseq, Inc. Anti-interleukin-1 receptor antagonist antibodies and uses thereof
US6426191B1 (en) 1998-04-03 2002-07-30 Hyseq, Inc. Assays involving an IL-1 receptor antagonist
US6337072B1 (en) 1998-04-03 2002-01-08 Hyseq, Inc. Interleukin-1 receptor antagonist and recombinant production thereof
US7157418B1 (en) 1998-07-22 2007-01-02 Osprey Pharmaceuticals, Ltd. Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
EP1346731B1 (de) * 1998-07-22 2006-12-06 Osprey Pharmaceuticals Limited Konjugate zur Behandlung von Entzündungskrankheiten und von assozierter Gewebeschädigung
US20030215421A1 (en) * 1999-07-21 2003-11-20 Mcdonald John R. Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
AU6278399A (en) * 1998-10-02 2000-04-26 Ludwig Institute For Cancer Research Tsg-5: a tnf-inducible gene
EP1390077B1 (de) 2001-05-02 2014-07-16 Purdue Research Foundation Behandlung und diagnose vom makrophagen-vermittelter erkrankung
WO2003083059A2 (en) * 2002-03-26 2003-10-09 Centocor, Inc. Mcp-1 mutant proteins, antibodies, compositions, methods and uses
AU2003225237A1 (en) * 2002-05-01 2003-11-17 Human Genome Sciences, Inc. Antibodies that specifically bind to chemokine beta-4
JP5175723B2 (ja) * 2005-07-05 2013-04-03 パーデュー・リサーチ・ファウンデーション 単球介在性疾患を治療するための組成物の調製
WO2008098112A2 (en) 2007-02-07 2008-08-14 Purdue Research Foundation Positron emission tomography imaging method
SG10201509499RA (en) 2010-11-19 2015-12-30 Eisai R&D Man Co Ltd Neutralizing anti-ccl20 antibodies

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276280A (en) * 1976-09-29 1981-06-30 Becton, Dickinson And Company Radiolabeled derivatives of folic acid
US4520112A (en) * 1983-03-09 1985-05-28 The Johns Hopkins University Assay method for organic calcium antagonist drugs and a kit for such an assay
US4656280A (en) * 1984-03-07 1987-04-07 E. I. Du Pont De Nemours And Company Radioiodinated dopamine receptor ligand
US4837003A (en) * 1984-09-13 1989-06-06 Mallinckrodt, Inc. Radiolabeled antibody fragments
US4659839A (en) * 1984-10-10 1987-04-21 Mallinckrodt, Inc. Coupling agents for radiolabeled antibody fragments
US5037630A (en) * 1985-01-14 1991-08-06 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4926869A (en) * 1986-01-16 1990-05-22 The General Hospital Corporation Method for the diagnosis and treatment of inflammation
US4732974A (en) * 1986-03-05 1988-03-22 Mallinckrodt, Inc. Metal ion labeling of carrier molecules
US4965392A (en) * 1987-03-26 1990-10-23 Neorx Corporation Chelating compounds for metal-radionuclide labeled proteins
ATE106898T1 (de) * 1987-03-26 1994-06-15 Neorx Corp Metall-radionuklid-markierte proteine und glykoproteine zur diagnose und therapie.
WO1990002762A1 (en) * 1988-09-02 1990-03-22 The Rockefeller University Macrophage-derived inflammatory mediator (mip-2)
US5196510A (en) * 1988-12-29 1993-03-23 Cytogen Corporation Molecular recognition units
US5198424A (en) * 1989-03-08 1993-03-30 Board Of Regents Of The University Of Oklahoma Functionally active selectin-derived peptides
US4986979A (en) * 1989-03-14 1991-01-22 Neorx Corporation Imaging tissue sites of inflammation
NZ233601A (en) * 1989-05-09 1997-06-24 Gen Hospital Corp N-terminal acylated peptides having an initial sequence met (or nle) -leu-phe and having a detectable label bound through dtpa or edta to a c-terminal lys or pu residue
US5179078A (en) * 1989-05-12 1993-01-12 Dana Farber Cancer Institute Method of suppressing tumor formation in vivo
US5241049A (en) * 1989-12-22 1993-08-31 Zymogenetics, Inc. Neutrophil chemoattractants
US5079228A (en) * 1990-02-05 1992-01-07 Board Of Regents, The University Of Texas System Peptide inhibitors of neutrophil activating factor induced chemotaxis
EP0600869A1 (de) * 1990-05-03 1994-06-15 New England Deaconess Hospital Corporation Synthetische peptide zur abbildung von arterien
IE913192A1 (en) * 1990-09-12 1992-02-25 Scripps Research Inst Active site of interleukin-8: polypeptide analogs and¹antibodies

Also Published As

Publication number Publication date
DE69309479D1 (de) 1997-05-07
AU5403294A (en) 1994-04-26
US5413778A (en) 1995-05-09
WO1994007542A2 (en) 1994-04-14
WO1994007542A3 (en) 1994-06-23
DE69309479T2 (de) 1997-10-23
CA2145983A1 (en) 1994-04-14
EP0662843B1 (de) 1997-04-02
CA2145983C (en) 2000-04-18
JPH08502075A (ja) 1996-03-05
EP0662843A1 (de) 1995-07-19
AU674039B2 (en) 1996-12-05

Similar Documents

Publication Publication Date Title
ATE150977T1 (de) Markiertes monocyte-chemoattractant- proteinmaterial und medizinische anwendung
ATE205728T1 (de) Markiertes interleukin-8 und seine medizinische anwendung
PT914345E (pt) Ligacao de anticorpos a receptores (ccr2) de proteina 1 de quimio-atraccao de monocitos (pqm-1)
DE69625802T2 (de) Impfstoffe gegen die pest
ITTO920646A0 (it) Procedimento e dispositivo per rilevare la funzionalita' cardiaca
DE69324487T2 (de) Rezeptorbindende region des diphtherietoxius
RU94045826A (ru) Моноклональные антитела против рецептора интерферона, с нейтрализующим действием против интерферона типа i
FR10C0016I2 (fr) Procedes et compositions s'appliquant au traitement de la glomerulonephrite
DK0523395T3 (da) Seroreaktive områder på proteinerne E1 og E2 i HPV 16
EP0674661A4 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis.
ATE397659T1 (de) Polyklonale antikörper gegen den menschlichen alpha-pdgf-rezeptor und dessen verwendung
FR2739292B1 (fr) Composition pharmaceutique utile pour la transfection d'acides nucleiques et ses utilisations
DE69728897D1 (de) Saeugetierchemokine
IT8423926A0 (it) Metodo diagnostico per la valutazione di parametri clinici mediante prelievo diretto dimateriali biologici e dispositivoper la sua attuazione.
ES2062754T3 (es) Eliminacion de linfocitos activados.
ATE207119T1 (de) Die herstellung von menschlichen, monoklonalen antikörpern, die gegen das oberflächenantigen von hepatitis b aktiv sind
AU3283693A (en) Specific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapy
RU94026276A (ru) Рецепторы интерлейкина-12 и антител
RU95102914A (ru) Способ отбора крупного рогатого скота на устойчивость к туберкулезу
IT1219864B (it) Procedimento per la biodegrazione di materiali organici contenenti lignia mediante microorganismi e impianto per la sua conduzione
UA15825A (uk) Спосіб одержаhhя пробіотика "лактосаh" для поросят